MIRA Pharmaceuticals (MIRA) Expected to Announce Quarterly Earnings on Monday

MIRA Pharmaceuticals (NASDAQ:MIRA) is projected to release its earnings data before the market opens on Monday, May 12th. Analysts expect MIRA Pharmaceuticals to post earnings of ($0.15) per share for the quarter.

MIRA Pharmaceuticals (NASDAQ:MIRA) last posted its quarterly earnings results on Friday, March 28th. The company reported ($0.15) EPS for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.14. On average, analysts expect MIRA Pharmaceuticals to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

MIRA Pharmaceuticals Stock Down 2.4 %

Shares of MIRA Pharmaceuticals stock opened at $1.22 on Friday. MIRA Pharmaceuticals has a 12-month low of $0.51 and a 12-month high of $5.01. The company has a market capitalization of $20.51 million, a price-to-earnings ratio of -2.18 and a beta of 1.93. The firm’s 50-day moving average price is $1.03 and its two-hundred day moving average price is $1.19.

About MIRA Pharmaceuticals

MIRA Pharmaceuticals, Inc operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder.